Medical Diagnostics Technology Investment

Medical Diagnostics Technology Investment — Healthcare · Mid North Coast · Asking $5,000,000

Multi-patented, non-invasive medical diagnostics technology developed over two decades of R&D Breath-based sensor approach positioned as an alternative to blood tests, imaging and biopsies Internal research indicates capability to diagnose a wide range of respiratory, cancer, metabolic and other conditions AI-driven software claims over 95% diagnostic accuracy Structured as a capital raise to…

DealProspect/Listings/Healthcare

Medical Diagnostics Technology Investment

ActiveHealthcareNew South WalesB2B & B2C

Find funding for this deal →View original listing ↗

Asking price

$5,000,000

Disclosed · AUD

Revenue

—

EBITDA (est.)

~$1,233,685

Estimated · comparable listings of this type and size · typically within ±25%

Typical multiple

~4.1×

comparable listings of this type and size · typically within ±25%

Brief

Multi-patented, non-invasive medical diagnostics technology developed over two decades of R&D
Breath-based sensor approach positioned as an alternative to blood tests, imaging and biopsies
Internal research indicates capability to diagnose a wide range of respiratory, cancer, metabolic and other conditions
AI-driven software claims over 95% diagnostic accuracy
Structured as a capital raise to fund large-scale clinical trials and regulatory approval
Regulatory pathways targeted include the FDA, EMA and TGA

Priced like this one

nearest on the figure this listing states